Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Michel

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 29, 2021
Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapyFrederik Marmé, Christine Solbach, Laura Michel, et al.
Geburtshilfe Und Frauenheilkunde|July 2, 2025
Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|March 16, 2026
Correction: Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Oncoimmunology|February 4, 2025
Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination siteMaria Paula Roberti, Pornpimol Charoentong, Yanhong Lyu, et al.
International Journal of Cancer|February 28, 2025
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utilityPaul Schwerd-Kleine, Roberto Würth, Tasneem Cheytan, et al.
Breast (Edinburgh, Scotland)|October 12, 2022
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 studyMattea Reinisch, Michael Untch, Rolf Mahlberg, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
The Lancet. Oncology|July 12, 2021
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trialsCarsten Denkert, Fenja Seither, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|June 29, 2021
Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapyFrederik Marmé, Christine Solbach, Laura Michel, et al.
Geburtshilfe Und Frauenheilkunde|July 2, 2025
Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|March 16, 2026
Correction: Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Oncoimmunology|February 4, 2025
Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination siteMaria Paula Roberti, Pornpimol Charoentong, Yanhong Lyu, et al.
International Journal of Cancer|February 28, 2025
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utilityPaul Schwerd-Kleine, Roberto Würth, Tasneem Cheytan, et al.
Breast (Edinburgh, Scotland)|October 12, 2022
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 studyMattea Reinisch, Michael Untch, Rolf Mahlberg, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
International Journal of Cancer|October 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experienceMario Hlevnjak, Sabine Heublein, Verena Thewes, et al.
The Lancet. Oncology|July 12, 2021
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trialsCarsten Denkert, Fenja Seither, Andreas Schneeweiss, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II StudyConstantin Pixberg, Christian Maurer, Katharina Smetanay, et al.
Pageof 3